Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 192

1.

The quest for epigenetic regulation underlying unisexual flower development in Cucumis melo.

Latrasse D, Rodriguez-Granados NY, Veluchamy A, Mariappan KG, Bevilacqua C, Crapart N, Camps C, Sommard V, Raynaud C, Dogimont C, Boualem A, Benhamed M, Bendahmane A.

Epigenetics Chromatin. 2017 Jun 6;10:22. doi: 10.1186/s13072-017-0132-6. eCollection 2017.

2.

Drawing Links from Transcriptome to Metabolites: The Evolution of Aroma in the Ripening Berry of Moscato Bianco (Vitis vinifera L.).

Costantini L, Kappel CD, Trenti M, Battilana J, Emanuelli F, Sordo M, Moretto M, Camps C, Larcher R, Delrot S, Grando MS.

Front Plant Sci. 2017 May 16;8:780. doi: 10.3389/fpls.2017.00780. eCollection 2017.

3.

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.

Rosell R, Dafni U, Felip E, Curioni-Fontecedro A, Gautschi O, Peters S, Massutí B, Palmero R, Aix SP, Carcereny E, Früh M, Pless M, Popat S, Kotsakis A, Cuffe S, Bidoli P, Favaretto A, Froesch P, Reguart N, Puente J, Coate L, Barlesi F, Rauch D, Thomas M, Camps C, Gómez-Codina J, Majem M, Porta R, Shah R, Hanrahan E, Kammler R, Ruepp B, Rabaglio M, Kassapian M, Karachaliou N, Tam R, Shames DS, Molina-Vila MA, Stahel RA; BELIEF collaborative group.

Lancet Respir Med. 2017 May;5(5):435-444. doi: 10.1016/S2213-2600(17)30129-7. Epub 2017 Apr 10.

PMID:
28408243
4.

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.

Usó M, Jantus-Lewintre E, Calabuig-Fariñas S, Blasco A, García Del Olmo E, Guijarro R, Martorell M, Camps C, Sirera R.

Oncoimmunology. 2016 Dec 7;6(1):e1260214. doi: 10.1080/2162402X.2016.1260214. eCollection 2017.

PMID:
28197383
5.

Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Hamblin A, Wordsworth S, Fermont JM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, Henderson S, Cutts A, Vavoulis DV, Housby N, Tomlinson I, Taylor JC, Schuh A.

PLoS Med. 2017 Feb 14;14(2):e1002230. doi: 10.1371/journal.pmed.1002230. eCollection 2017 Feb.

6.

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.

Malapelle U, Sirera R, Jantus-Lewintre E, Reclusa P, Calabuig-Fariñas S, Blasco A, Pisapia P, Rolfo C, Camps C.

Expert Rev Mol Diagn. 2017 Mar;17(3):209-215. doi: 10.1080/14737159.2017.1288568. Epub 2017 Feb 9.

PMID:
28129709
7.

Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.

Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C.

Clin Transl Oncol. 2017 Jun;19(6):651-657. doi: 10.1007/s12094-016-1599-5. Epub 2017 Jan 4. Review.

PMID:
28054319
8.

Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.

Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R; Spanish Lung Cancer Group.

Clin Lung Cancer. 2017 Mar;18(2):178-188.e4. doi: 10.1016/j.cllc.2016.08.007. Epub 2016 Nov 9.

PMID:
27908619
9.

[Treatment of partial articular fractures of the distal radius in active young adults].

Camps C, Durand A, Merle M.

Hand Surg Rehabil. 2016 Dec;35S:S126-S132. doi: 10.1016/j.hansur.2016.07.008. Epub 2016 Oct 24. French.

PMID:
27890197
10.

[Treatment of intra-articular malunion of the distal radius of young active patients].

Durand A, Camps C, Merle M.

Hand Surg Rehabil. 2016 Dec;35S:S105-S111. doi: 10.1016/j.hansur.2016.03.009. Epub 2016 Oct 13. French.

PMID:
27890193
11.

Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?

Calabuig-Fariñas S, Jantus-Lewintre E, Herreros-Pomares A, Camps C.

Transl Lung Cancer Res. 2016 Oct;5(5):466-482. Review.

12.

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.

Camps C, Petousi N, Bento C, Cario H, Copley RR, McMullin MF, van Wijk R, Ratcliffe PJ, Robbins PA, Taylor JC; WGS500 Consortium.

Haematologica. 2016 Nov;101(11):1306-1318. Epub 2016 Sep 20.

13.

Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.

Kaisaki PJ, Cutts A, Popitsch N, Camps C, Pentony MM, Wilson G, Page S, Kaur K, Vavoulis D, Henderson S, Gupta A, Middleton MR, Karydis I, Talbot DC, Schuh A, Taylor JC.

PLoS One. 2016 Sep 14;11(9):e0162809. doi: 10.1371/journal.pone.0162809. eCollection 2016.

14.

European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish.

Guillem V, Camps C, Carrato A, Díaz-Rubio E, Gascón P.

Clin Transl Oncol. 2017 Mar;19(3):288-290. doi: 10.1007/s12094-016-1545-6. Epub 2016 Sep 7.

PMID:
27604422
15.

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.

Usó M, Jantus-Lewintre E, Bremnes RM, Calabuig S, Blasco A, Pastor E, Borreda I, Molina-Pinelo S, Paz-Ares L, Guijarro R, Martorell M, Forteza J, Camps C, Sirera R.

Oncotarget. 2016 Aug 16;7(33):52849-52861. doi: 10.18632/oncotarget.10811.

16.

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.

Molina-Pinelo S, Salinas A, Moreno-Mata N, Ferrer I, Suarez R, Andrés-León E, Rodríguez-Paredes M, Gutekunst J, Jantus-Lewintre E, Camps C, Carnero A, Paz-Ares L.

Oncotarget. 2016 Jul 15. doi: 10.18632/oncotarget.10611. [Epub ahead of print]

17.

62P Novel therapeutic strategies in NSCLC: Lung-tumorspheres as an effective in vitro screening platform.

Maravilla EM, Pomares AH, Calabuig-Fariñas S, Lewintre EJ, Lucas R, Guijarro R, Madriaga AI, Cordellat AB, Camps C.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S81. doi: 10.1016/S1556-0864(16)30175-7. Epub 2016 Apr 15. No abstract available.

18.

149P: The role of CTCs and cfDNA for diagnosis and monitoring of EGFR mutations in advanced NSCLC patients.

Calabuig-Fariñas S, Lewintre EJ, Mayo-De-Las-Casas C, Cordellat AB, Molina-Vila MA, Rosell R, Camps C.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S123. doi: 10.1016/S1556-0864(16)30259-3. Epub 2016 Apr 15. No abstract available.

19.

114P: Expression analysis of tumorspheres from non-small cell lung cancer show significant differences in CSC-markers and signaling pathways.

Pomares AH, Maravilla EM, Lafuente B, Calabuig-Fariñas S, Cordellat AB, Guijarro R, Farrás R, Lewintre EJ, Camps C.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S105. doi: 10.1016/S1556-0864(16)30227-1. Epub 2016 Apr 15. No abstract available.

20.

Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi Technique.

Camps C, Albanell J, Antón A, Aranda E, Carrato A, Cassinello J, Castellano D, Cruz JJ, Garrido P, Guillem V, Grávalos C, López G, Llorente C, Lorenzo A, Lluch A, Ignacio E, Díaz-Rubio E.

J Natl Compr Canc Netw. 2016 May;14(5):553-8.

PMID:
27160233

Supplemental Content

Loading ...
Support Center